Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.
Machado, Fabiana S; Dutra, Walderez O; Esper, Lisia; Gollob, Kenneth J; Teixeira, Mauro M; Factor, Stephen M; Weiss, Louis M; Nagajyothi, Fnu; Tanowitz, Herbert B; Garg, Nisha J.
; 34(6): 753-70, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23076807
Evaluation of clinical and immunopathological features of different infective doses of Trypanosoma cruzi in dogs during the acute phase.
Molecular mechanisms of myocarditis caused by Trypanosoma cruzi.
Trypanosoma cruzi: biotherapy made from trypomastigote modulates the inflammatory response.
Cardiac damage induced by immunization with heat-killed Trypanosoma cruzi is not antibody mediated.
Toll-like receptor-2 and interleukin-6 mediate cardiomyocyte protection from apoptosis during Trypanosoma cruzi murine infection.
The enigmatic role of cholinergic reflex in the pathogenesis of Chagas disease.
A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.
Evolution of infection in mice inoculated by the oral route with different developmental forms of Trypanosoma cruzi I and II.
Inhibitory Receptor Expression on CD8+ T Cells Is Linked to Functional Responses against Trypanosoma cruzi Antigens in Chronic Chagasic Patients.
Immunoregulatory networks in human Chagas disease.